AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2017
Dec 5, 2017
29745_dirs_2017-12-05_4e764559-6582-4af3-a268-dd57df725371.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-12-03
Reporting Person: Ricks David A (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-03 | Common Stock | M | 5496 | — | Acquired | 110059 | Direct |
| 2017-12-03 | Common Stock | F | 2601 | $85.32 | Disposed | 107458 | Direct |
| 2017-06-14 | Common Stock | G | 25 | — | Disposed | 107433 | Direct |
| 2017-05-05 | Common Stock | G | 357 | — | Disposed | 107076 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-03 | Restricted Stock Unit | $0.0 | M | 5496 | Disposed | 2017-12-03 | Common Stock (5496.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5264 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29